| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 144, Issue 5 1767-1776, Copyright © 1990 by American Association of Immunologists
ARTICLES |
JJ Ruegemer, SN Ho, JA Augustine, JW Schlager, MP Bell, DJ McKean and RT Abraham
Department of Immunology, Mayo Clinic, Rochester, MN 55905.
Previous studies suggested that the potent immunosuppressive activities of transforming growth factor-beta (TGF-beta) were mediated in part through the inhibition of IL-2-dependent S-phase progression and mitosis of activated T cells. To further investigate the mechanism of T cell growth inhibition by TGF-beta, two constitutively activated murine T cell clones were employed as defined model systems for the growth factor-dependent phase of T cell proliferation. The Th cell line, HT-2, proliferated in response to either IL-2 or IL-4, whereas the cytotoxic T cell line, CT6, exhibited strict dependence on IL-2 for growth stimulation. In both cell lines, picomolar concentrations of TGF-beta inhibited S-phase progression stimulated by IL-2 or IL-4. TGF-beta pretreatment decreased the expression of high affinity IL-2R on HT-2 cells, but not on CT6 cells. In contrast, IL-2-stimulated transferrin receptor expression was markedly inhibited by TGF-beta in both T cell lines. Analyses of growth factor-dependent specific mRNA accumulation revealed that TGF-beta exerted selective inhibitory effects on gene expression in HT-2 and CT6 cells. TGF-beta significantly reduced early (1 to 2 h) increases in c-myc mRNA levels stimulated by IL-2 or IL-4 in both cell lines. In HT-2 cells, TGF-beta pretreatment also inhibited the early increase in granulocyte-macrophage CSF mRNA stimulated by IL- 2 or IL-4. The inhibition of c-myc and granulocyte-macrophage cyte- macrophage CSF gene expression by TGF-beta was explained, at least in part, by suppression of the growth factor-dependent transcriptional activation of these genes. These studies suggest that inhibition of c- myc gene transcription may play a fundamental role in the antiproliferative effect of TGF-beta on IL-2- or IL-4-stimulated T cells.
This article has been cited by other articles:
|
|
 |
|
  S. H. Wrzesinski, Y. Y. Wan, and R. A. Flavell Transforming Growth Factor-{beta} and the Immune Response: Implications for Anticancer Therapy Clin. Cancer Res., September 15, 2007; 13(18): 5262 - 5270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eriksson, S. K. Meadows, C. R. Wira, and C. L. Sentman Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-{beta} J. Leukoc. Biol., September 1, 2004; 76(3): 667 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Nelson, T. P. Martyak, L. J. Thompson, J. J. Moon, and T. Wang Uncoupling of Promitogenic and Antiapoptotic Functions of IL-2 by Smad-Dependent TGF-{beta} Signaling J. Immunol., June 1, 2003; 170(11): 5563 - 5570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mukherjee, P. K. Maiti, and D. Nandi Role of CD80, CD86, and CTLA4 on mouse CD4+ T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin J. Leukoc. Biol., November 1, 2002; 72(5): 921 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fleischer, E. Grage-Griebenow, B. Kasper, H. Heine, M. Ernst, E. Brandt, H.-D. Flad, and F. Petersen Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells J. Immunol., July 15, 2002; 169(2): 770 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Leveen, J. Larsson, M. Ehinger, C. M. Cilio, M. Sundler, L. J. Sjostrand, R. Holmdahl, and S. Karlsson Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable Blood, June 28, 2002; 100(2): 560 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-C. Sheu, R.-H. Lin, H.-C. Lien, H.-N. Ho, S.-M. Hsu, and S.-C. Huang Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer J. Immunol., September 1, 2001; 167(5): 2972 - 2978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.G.S. Buggins, N. Lea, J. Gaken, D. Darling, F. Farzaneh, G.J. Mufti, and W.J.R. Hirst Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells Blood, November 15, 1999; 94(10): 3479 - 3490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bellone, A. Turletti, E. Artusio, K. Mareschi, A. Carbone, D. Tibaudi, A. Robecchi, G. Emanuelli, and U. Rodeck Tumor-Associated Transforming Growth Factor-{beta} and Interleukin-10 Contribute to a Systemic Th2 Immune Phenotype in Pancreatic Carcinoma Patients Am. J. Pathol., August 1, 1999; 155(2): 537 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Won, H. Kim, E. J. Park, Y. Hong, S.-J. Kim, and Y. Yun Tumorigenicity of Mouse Thymoma Is Suppressed by Soluble Type II Transforming Growth Factor {beta} Receptor Therapy Cancer Res., March 1, 1999; 59(6): 1273 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sudarshan, J. Galon, Y.-j. Zhou, and J. J. O'Shea TGF-{beta} Does Not Inhibit IL-12- and IL-2-Induced Activation of Janus Kinases and STATs J. Immunol., March 1, 1999; 162(5): 2974 - 2981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pardoux, X. Ma, S. Gobert, S. Pellegrini, P. Mayeux, F. Gay, G. Trinchieri, and S. Chouaib Downregulation of Interleukin-12 (IL-12) Responsiveness in Human T Cells by Transforming Growth Factor-beta : Relationship With IL-12 Signaling Blood, March 1, 1999; 93(5): 1448 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Genestier, S. Kasibhatla, T. Brunner, and D. R. Green Transforming Growth Factor beta 1 Inhibits Fas Ligand Expression and Subsequent Activation-induced Cell Death in T Cells via Downregulation of c-Myc J. Exp. Med., January 18, 1999; 189(2): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lingnau, P. Hoehn, S. Kerdine, S. Koelsch, C. Neudoerfl, N. Palm, E. Ruede, and E. Schmitt IL-4 in Combination with TGF-{beta} Favors an Alternative Pathway of Th1 Development Independent of IL-12 J. Immunol., November 1, 1998; 161(9): 4709 - 4718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takeuchi, P. Alard, and J. W. Streilein TGF-{beta} Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells J. Immunol., February 15, 1998; 160(4): 1589 - 1597. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
